JCR Pharmaceuticals Co., Ltd. Declares Interim Dividend for the Fiscal Year Ending March 31, 2024, Payable on December 8, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
October 25, 2023 at 12:30 pm IST
Share
JCR Pharmaceuticals Co., Ltd. announced that its Board of Directors resolved at a meeting held on October 25, 2023 to distribute retained earnings (interim dividend) with the record date being September 30, 2023. Guided by the foregoing policy, JCR has declared an interim dividend of JPY 10.00 per share for the fiscal year ending March 31, 2024. Effective date is on December 8, 2023. Dividend resource is from Retained earnings.
The company provided dividend guidance for the fiscal year ending March 31, 2024. For the year, the company expects dividend of JPY 10.00 per share.
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
JCR Pharmaceuticals Co., Ltd. Declares Interim Dividend for the Fiscal Year Ending March 31, 2024, Payable on December 8, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024